166 related articles for article (PubMed ID: 6235140)
1. Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
Rendina GM; Donadio C; Fabri M; Mazzoni P; Nazzicone P
Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):285-91. PubMed ID: 6235140
[TBL] [Abstract][Full Text] [Related]
2. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE
Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
[TBL] [Abstract][Full Text] [Related]
4. Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
van Veelen H; Willemse PH; Tjabbes T; Schweitzer MJ; Sleijfer DT
Cancer; 1986 Jul; 58(1):7-13. PubMed ID: 2939943
[TBL] [Abstract][Full Text] [Related]
5. Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen.
Kauppila A; Vihko R
Acta Obstet Gynecol Scand; 1981; 60(6):589-90. PubMed ID: 6461159
[No Abstract] [Full Text] [Related]
6. Tamoxifen and aminoglutethimide in the management of patients with advanced endometrial carcinoma not responsive to medroxyprogesterone.
Quinn MA; Campbell JJ; Murray R; Pepperell RJ
Aust N Z J Obstet Gynaecol; 1981 Nov; 21(4):226-9. PubMed ID: 6951563
[TBL] [Abstract][Full Text] [Related]
7. Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.
Laatikainen T; Nieminen U; Adlercreutz H
Acta Obstet Gynecol Scand; 1979; 58(1):95-9. PubMed ID: 419965
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant gestagen therapy in stage I endometrial cancer].
Lahousen M; Pickel H
Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status.
Ayoub J; Audet-Lapointe P; Méthot Y; Hanley J; Beaulieu R; Chemaly R; Cormier A; Déry JP; Drouin P; Gauthier P
Gynecol Oncol; 1988 Oct; 31(2):327-37. PubMed ID: 2971597
[TBL] [Abstract][Full Text] [Related]
10. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
Beltrán M; Alonso MC; Ojeda MB; Izquierdo A; Ferrer J; Picó C; Anglada L; Catalán G; Batiste-Alentorn E; Tusquets I
Ann Oncol; 1991 Jul; 2(7):495-9. PubMed ID: 1832944
[TBL] [Abstract][Full Text] [Related]
11. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Feng YJ; Zhang XY
Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
[TBL] [Abstract][Full Text] [Related]
12. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
Byrne MJ; Gebski V; Forbes J; Tattersall MH; Simes RJ; Coates AS; Dewar J; Lunn M; Flower C; Gill PG; Stewart J
J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
[TBL] [Abstract][Full Text] [Related]
13. Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model.
Zaino RJ; Satyaswaroop PG; Mortel R
Cancer Res; 1985 Feb; 45(2):539-41. PubMed ID: 3967228
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
15. [The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
Husslein P; Egarter C; Eppel W; Salzer H; Spona J
Zentralbl Gynakol; 1988; 110(20):1277-82. PubMed ID: 2977043
[TBL] [Abstract][Full Text] [Related]
16. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
[TBL] [Abstract][Full Text] [Related]
17. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
18. [Progestins in combined treatment of endometrial cancer].
Voznyĭ EK; Titova VA
Sov Med; 1990; (9):102-7. PubMed ID: 2148437
[No Abstract] [Full Text] [Related]
19. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
[TBL] [Abstract][Full Text] [Related]
20. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
Quinn MA; Cauchi M; Fortune D
Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]